Not checkedNot checked for notices yet.
Ki-67 proliferation index and clinicopathological patterns in colorectal carcinomas
Bhagya Lakshmi A, Sreelekha A, Kasi Babu A and 2 more
Journal of Clinical and Scientific Research · 2015
doi:10.15380/2277-5706.jcsr.14.039 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Background: Tumour, Node, Metastasis (TNM) staging system provides useful prognostic information in patients with colorectal carcinoma (CRC). An improved prognostication and patient survival may be achieved by employing immunohistochemistry studies with proliferation markers like Ki-67. Materials and methods: We prospectively studied 51 patients with CRC and evaluated the clinicopathological patterns of CRC and the relationship of with the clinicopathological variables Results: Their mean age was 48 (range 17-75) years; majority (64.7%) were males. Rectum was the most common subsite affected (45.1%). Histopathologically most of the tumours (86.3%) were usual type adenocarcinomas and were of grade 1 morphology (51%). The Ki-67 proliferation index (PI) ranged from 8.4% to 84.4%. The mean PI was greater in patients aged less than or equal to 50 years than in those aged above 50 years, in males than females, in rectal cancers than colonic cancers. It was greater in mucinous carcinomas than usual type adenocarcinomas, in grade 3 tumours than lower grade tumours (grades 1 and 2) and in T4 than T3 and T2 tumours. There was a significant positive correlation between the PI values and grade of the tumour. Conclusion: We concluded that Ki-67 proliferation marker may be useful as an additional tool to assess the tumour aggressiveness with respect to certain clinicopathological parameters in colorectal carcinomas.
Abstract licence: CC BY-NC-SA
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.